These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15561877)

  • 1. In vitro activities of OPT-80 and comparator drugs against intestinal bacteria.
    Finegold SM; Molitoris D; Vaisanen ML; Song Y; Liu C; Bolaños M
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4898-902. PubMed ID: 15561877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species.
    Credito KL; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4430-4. PubMed ID: 15504874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of telavancin on human intestinal microflora.
    Rashid MU; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2011 Dec; 38(6):474-9. PubMed ID: 21982049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dalbavancin on the normal intestinal microflora.
    Nord CE; Rasmanis G; Wahlund E
    J Antimicrob Chemother; 2006 Sep; 58(3):627-31. PubMed ID: 16840427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria.
    Citron DM; Warren YA; Tyrrell KL; Merriam V; Goldstein EJ
    J Antimicrob Chemother; 2009 May; 63(5):972-6. PubMed ID: 19240076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.
    Finegold SM; John SS; Vu AW; Li CM; Molitoris D; Song Y; Liu C; Wexler HM
    Anaerobe; 2004 Aug; 10(4):205-11. PubMed ID: 16701520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut.
    van Vliet MJ; Tissing WJ; Dun CA; Meessen NE; Kamps WA; de Bont ES; Harmsen HJ
    Clin Infect Dis; 2009 Jul; 49(2):262-70. PubMed ID: 19514856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections.
    Edlund C; Nord CE
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():41-8; discussion 63-5. PubMed ID: 11051623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activity of several cytostatic drugs against aerobic and anaerobic intestinal bacteria].
    Vetere A; Giuliano M; Pantosti A; Panichi G
    Boll Ist Sieroter Milan; 1984; 63(6):505-9. PubMed ID: 6534396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility of preoperative normal conjunctival bacteria.
    Miño de Kaspar H; Koss MJ; He L; Blumenkranz MS; Ta CN
    Am J Ophthalmol; 2005 Apr; 139(4):730-3. PubMed ID: 15808182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
    Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of imipenem against gram-positive anaerobic bacteria.
    Dubreuil L; Devos J; Romond C
    Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the environment on gram-negative facultative anaerobic and aerobic intestinal flora in infants].
    Horák A; Pomykal J; Kithierová E; Malý M; Truksová B; Zadáková M
    Cesk Pediatr; 1984 Jan; 39(1):50-3. PubMed ID: 6705106
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli.
    Donskey CJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S62-9. PubMed ID: 16894517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo activity of nifurzide and nifuroxazide in intestinal bacteria in man and gnotobiotic mice.
    Leonard F; Andremont A; Tancrede C
    J Appl Bacteriol; 1985 Jun; 58(6):545-53. PubMed ID: 4030525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro time-kill assessment of linezolid and anaerobic bacteria.
    Yagi BH; Zurenko GE
    Anaerobe; 2003 Feb; 9(1):1-3. PubMed ID: 16887680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.